Created for healthcare providers and empowered individuals alike, this 8-hour psychedelic webinar series is rooted in evidence-based medicine and first-hand experiences in psychedelic facilitation.

Scroll down for details about each of the included modules.

MODULE 1

In this module we examine the pharmacology of the “classic psychedelic” namely psilocybin (the active constituent in “magic mushrooms”).

The effects of this medicine on brain function, chemistry, and neuronal firing will be reviewed, and the concepts of the default mode network (DMN), brain entropy, and child consciousness will be introduced.

We will also take a closer look at the role of mystical experiences, and what spirituality has to do with psychological and physiological healing.

MODULE 2

What happens when we take extremely diluted doses of LSD and/or psilocybin? Everything – or nothing, depending on who you ask.

Peppered with real cases of people who have tried microdosing, this module outlines the dosage protocols, critiques the studies currently available on this new way of taking psychedelics, and summarizes their findings.

The proposed mechanisms of action of microdosing will be explained, along with safety considerations and drug-drug interactions.

MODULE 3

How on earth did ketamine, an anesthesia drug, come to be used for psychiatric purposes? We will review the history of this unique molecule, examine its known mechanisms of action, and explore the theories of how and why it treats depression.

After juxtaposing SSRIs with ketamine, we will learn about the several different paradigms for administering the drug, from small microdoses to large psychedelic doses and everything in between.

MODULE 4

After reviewing the history of this unique molecule, we will dissect its pharmacology to understand just why it pairs so well with counseling. The results of recent studies of MDMA-assisted psychotherapy in the treatment of post-traumatic stress disorder (PTSD) will be presented, along with a video clip from an actual session recorded during one of the studies.

MDMA’s side effect profile will be reviewed, along with its drug-drug interactions and other notes on safety.

MODULE 5

We will examine the use of psychedelic medicines in the treatment of alcohol use disorder (alcoholism), smoking, and other substance use disorders (including crack, methamphetamine, cocaine, and opiates).

Detail will be offered on psilocybin, LSD, ketamine, ayahuasca, and ibogaine. The safety, risks, and contraindications for these medicines will also be reviewed, and basic psychedelic “troubleshooting” tips will be offered.

MODULE 6

Supporting somebody on psychedelics is quite different than facilitating a regular therapy session.

Tips for handling common situations during psychedelic sessions will be offered, along with suggestions on how to maximize the potential for healing and minimize the risk of a “bad trip.”

Guidelines for designing a healing space, using directive and non-directive interventions, and supporting clients in difficult moments will be explained.

We will consider the importance of integration work and offer recommendations for how often people should take psychedelics to achieve their health goals.

MODULE 7

Experience the holistic elements of psychedelic sessions in this interactive module. Set intentions, immerse in music, and reflect with journaling prompts. Requires a journal, pen, quiet setting, eye mask, and headphones for a 30-minute journey.